Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Cash & Equivalents
$517.00M
Quarterly · Period ending: · USD
BIO Cash & Equivalents
Latest reported$531.80Mperiod ending
Latest reported$531.80Mperiod ending
BIO FY Cash & Equivalents ($6.00M → $531.80M)
Annual Cash & Equivalents
High-resolution chart · PNG
BIO cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 531,799,999 | |
| 488,100,000 | |
| 403,800,000 | |
| 434,215,000 | |
| 470,783,000 | |
| 662,205,000 | |
| 660,672,000 | |
| 431,526,000 | |
| 383,824,000 | |
| 456,264,000 | |
| 457,549,000 | |
| 413,251,000 | |
| 331,551,000 | |
| 463,388,000 | |
| 574,231,000 | |
| 906,551,000 | |
| 649,938,000 | |
| 204,524,000 | |
| 161,764,000 | |
| 223,607,000 | |
| 296,716,000 | |
| 195,734,000 | |
| 65,395,000 | |
| 27,733,000 | |
| 47,129,000 | |
| 13,954,000 | |
| 17,100,000 | |
| 10,100,000 | |
| 10,800,000 | |
| 9,400,000 | |
| 14,800,000 | |
| 3,800,000 | |
| 3,100,000 | |
| 2,700,000 | |
| 4,800,000 | |
| 2,000,000 | |
| 2,900,000 | |
| 4,000,000 | |
| 1,900,000 | |
| 2,100,000 | |
| 6,000,000 |